journal article·2014-03

Poly(ethylene glycol) methacrylate hydrolyzable microspheres for transient vascular embolization

Stéphanie Louguet, Valentin Verret, Laurent Bédouet, Emeline Servais, Florentina Pascale, Michel Wassef, Denis Labarre, Alexandre Laurent, Laurence Moine

Acta Biomaterialia· Volume 10· Issue 3
Publisher page

Abstract

Poly(ethylene glycol) methacrylate (PEGMA) hydrolyzable microspheres intended for biomedical applications were readily prepared from poly(lactide-co-glycolide) (PLGA)-poly(ethylene glycol) (PEG)-PLGA crosslinker and PEGMA as a monomer using a suspension polymerization process. Additional co-monomers, methacrylic acid and 2-methylene-1,3-dioxepane (MDO), were incorporated into the initial formulation to improve the properties of the microspheres. All synthesized microspheres were spherical in shape, calibrated in the 300-500 μm range, swelled in phosphate-buffered saline (PBS) and easily injectable through a microcatheter. Hydrolytic degradation experiments performed in PBS at 37 °C showed that all of the formulations tested were totally degraded in less than 2 days. The resulting degradation products were a mixture of low-molecular-weight compounds (PEG, lactic and glycolic acids) and water-soluble polymethacrylate chains having molecular weights below the threshold for renal filtration of 50 kg mol(-1) for the microspheres containing MDO. Both the microspheres and the degradation products were determined to exhibit minimal cytotoxicity against L929 fibroblasts. Additionally, in vivo implantation in a subcutaneous rabbit model supported the in vitro results of a rapid degradation rate of microspheres and provided only a mild and transient inflammatory reaction comparable to that of the control group.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Intracranial Aneurysms: Treatment and Complications · Electrospun Nanofibers in Biomedical Applications · Vascular Malformations Diagnosis and Treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (43)

Show source-provided references
1. Polyvinyl alcohol sponge for embolotherapy: particle size and morphology
2. Polyvinyl alcohol particle size and suspension characteristics
3. The size of gelatin sponge particles: differences with preparation method10.1007/s00270-006-0059-y ↗
4. New intra-arterial drug delivery system for the treatment of liver cancer: preclinical assessment in a rabbit model of liver cancer10.1158/1078-0432.CCR-05-2225 ↗
5. Chemoembolization of hepatocellular carcinoma with drug eluting beads: efficacy and doxorubicin pharmacokinetics10.1016/j.jhep.2006.10.020 ↗
6. Transcatheter occlusion of abdominal tumors10.1148/120.3.539 ↗
7. Gelatin sponge in therapeutic neuroradiology: a subject review10.1148/radiology.141.1.7027309 ↗
8. Transcatheter gelfoam embolization in abdominal, retroperitoneal, and pelvic hemorrhage10.1148/radiology.136.2.6967615 ↗
9. A new porcine sponge material for temporary embolization: an experimental short-term pilot study in swine10.1007/s00270-004-0299-7 ↗
10. Gelatine sponge particles: handling characteristics for endovascular use10.1053/j.tvir.2008.03.002 ↗
11. Magnetic resonance angiography of uterine artery: changes with embolization using gelatin sponge particles alone for fibroids10.1007/s00270-006-0196-3 ↗
12. Comparison of long-term effects between intra-arterially delivered ethanol and gelfoam for the treatment of severe arterioportal shunt in patients with hepatocellular carcinoma10.3748/wjg.v10.i6.825 ↗
13. Repeated intra-arterial chemotherapy combined with mitomycin C and degradable starch microspheres in inoperable metastatic hepatic cancer
14. Transarterial chemoembolization with degradable starch microspheres, irinotecan, and mitomycin-C in patients with liver metastases10.1016/j.gassur.2005.08.004 ↗
15. Effect of transcatheter arterial infusion chemotherapy using iodized oil and degradable starch microspheres for hepatocellular carcinoma10.1007/s00535-012-0537-8 ↗
16. A preclinical study of the safety and efficacy of Occlusin 500 Artificial Embolization Device in sheep10.1007/s00270-011-0218-7 ↗
17. Elasticity and viscoelasticity of embolization microspheres10.1016/j.jmbbm.2011.08.001 ↗
18. Late degradation tissue response to poly (L-lactid) bone plates and screws10.1016/0142-9612(95)91092-D ↗
19. Fate of water-soluble polymers administered via different routes10.1002/jps.2600840316 ↗
20. Soluble polymer carriers for the treatment of cancer: the importance of molecular architecture10.1021/ar900035f ↗
21. Synthesis of poly-∈-caprolactone via a free radical mechanism. Free radical ring-opening polymerization of 2-methylene-1,3-dioxepane10.1002/pol.1982.170201101 ↗
22. Bioerodible hydrogels based on photopolymerized poly(ethylene glycol)-co-poly(α-hydroxy acid) diacrylate macromers10.1021/ma00056a005 ↗
23. Chemistry, chances and limitations of the radical ring-opening polymerization of cyclic ketene acetals for the synthesis of degradable polyesters10.1039/c0py00040j ↗
24. Hydrogels in biology and medicine: from molecular principles to bionanotechnology10.1002/adma.200501612 ↗
25. Release behaviour of high molecular weight solutes from poly(ethylene glycol)-based degradable networks10.1021/ma9915024 ↗
26. In situ forming degradable networks and their application in tissue engineering and drug delivery10.1016/S0168-3659(01)00500-4 ↗
27. End-group effects on the properties of PEG-co-PGA hydrogels10.1016/j.actbio.2009.02.030 ↗
28. Hydrolytic degradation of poly(D, L-lactide-co-glycolide 50/50)-di-acrylate network as studied by liquid chromatography-mass spectrometry10.1016/j.polymdegradstab.2011.05.022 ↗
29. Biodegradable three-dimensional networks of poly(dimethylamino ethyl methacrylate). Synthesis, characterization and in vitro studies of structural degradation and cytotoxicity10.1016/S0142-9612(99)00223-9 ↗
30. The influence of polymer topology on pharmacokinetics: differences between cyclic and linear PEGylated poly(acrylic acid) comb polymers10.1016/j.jconrel.2009.05.021 ↗
31. Novel amphiphilic, biodegradable, biocompatible, cross-linkable copolymers: synthesis, characterization and drug delivery applications10.1039/c2py20364b ↗
32. Effect of molecular weight (Mw) of N-(2-hydroxypropyl)methacrylamide copolymers on body distribution and rate of excretion after subcutaneous, intraperitoneal, and intravenous administration to rats10.1002/jbm.820211106 ↗
33. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice10.1002/jps.2600830432 ↗
34. Dependence of pharmacokinetics and biodistribution on polymer architecture: effect of cyclic versus linear polymers10.1021/ja900062u ↗
35. Characterization of the membrane-destabilizing properties of different pH-sensitive methacrylic acid copolymers10.1016/S0005-2736(03)00137-8 ↗
36. Hemocompatibility and cytocompatibility of styrenesulfonate-grafted PDMS-polyurethane-HEMA hydrogel10.1016/j.colsurfb.2008.12.020 ↗
37. Longterm histopathologic follow-up of bronchial arteries after therapeutic embolization with polyvinyl alcohol (Ivalon) in patients with cystic fibrosis10.1016/S0046-8177(88)80204-1 ↗
38. Histologic long-term follow-up after embolization with polyvinyl alcohol particles
39. Pathologic features of uteri and leiomyomas following uterine artery embolization for leiomyomas10.1097/00000478-200302000-00004 ↗
40. Recanalization and particle exclusion after embolization10.1016/j.fertnstert.2007.12.015 ↗
41. Cellular and molecular dynamics in the foreign body reaction10.1089/ten.2006.12.1955 ↗
42. Degradable gelatin microspheres as an embolic agent: an experimental study in a rabbit renal model10.3348/kjr.2007.8.5.418 ↗
43. Targeting and recanalization after embolization with calibrated resorbable microspheres versus hand-cut gelatin sponge particles in a porcine kidney model10.1016/j.jvir.2013.05.058 ↗